IP Due Diligence is just one component in the swath of information taken into account during life sciences dealmaking. Hear from investment banker Rick Aldridge and Director of Business Development JM Lee as they discuss the state of life sciences deal-making today and anticipate potential shifts in the landscape.

Topics of discussion will include:

• The interaction between investment bankers and business leaders in the proliferation of new deals
• Key market concerns in life science investment
• The impact of due diligence on dealmaking
• What due diligence practitioners should consider when undertaking due diligence review